Lifestyle interventions in preventing new type 2 diabetes in Asian populations

Internal and Emergency Medicine

Volumn 11, Issue 3, 2016, Pages 375-384

  Modesti, Pietro Amedeo ^a   Galanti, Giorgio ^a   Cala’, Piergiuseppe ^b   Calabrese, Maria ^c  

^a UNIVERSITY OF FLORENCE   (Italy)

^b Regione Toscana   (Italy)

^c MISERICORDIA E DOLCE HOSPITAL   (Italy)

Author keywords

Ethnic minority groups; Ethnicity; IDF geographical regions; Meta analysis; Type 2 diabetes prevention

Indexed keywords

ADULT; ASIAN CONTINENTAL ANCESTRY GROUP; DIABETES MELLITUS, TYPE 2; EPIDEMIOLOGY; ETHNOLOGY; EUROPE; FEMALE; HUMAN; INCIDENCE; LIFESTYLE; MALE; META ANALYSIS; MIDDLE AGED; MIGRANT; MINORITY GROUP; PRIMARY PREVENTION; PROCEDURES; RISK FACTOR; RISK REDUCTION; SEVERITY OF ILLNESS INDEX; STATISTICS AND NUMERICAL DATA;

ADULT; ASIAN CONTINENTAL ANCESTRY GROUP; DIABETES MELLITUS, TYPE 2; EMIGRANTS AND IMMIGRANTS; EUROPE; FEMALE; HUMANS; INCIDENCE; LIFE STYLE; MALE; MIDDLE AGED; MINORITY GROUPS; PRIMARY PREVENTION; RISK FACTORS; RISK REDUCTION BEHAVIOR; SEVERITY OF ILLNESS INDEX;

EID: 84945219370     PISSN: 18280447     EISSN: 19709366     Source Type: Journal    
DOI: 10.1007/s11739-015-1325-2     Document Type: Review

References (73)

1. Goldberg R, Temprosa M, Otvos J, Brunzell J, Marcovina S, Mather K, Arakaki R, Watson K, Horton E, Barrett-Connor E (2013) Lifestyle and metformin treatment favorably influence lipoprotein subfraction distribution in the Diabetes Prevention Program. J Clin Endocrinol Metab 98(10):3989–3998. doi:10.1210/jc.2013-1452
2. Pan XR, Li GW, Hu YH, Wang JX, Yang WY, An ZX, Hu ZX, Lin J, Xiao JZ, Cao HB, Liu PA, Jiang XG, Jiang YY, Wang JP, Zheng H, Zhang H, Bennett PH, Howard BV (1997) Effects of diet and exercise in preventing NIDDM in people with impaired glucose tolerance. The Da Qing IGT and Diabetes Study. Diabetes Care 20(4):537–544. doi:10.2337/diacare.20.4.537
3. Knowler WC, Barrett-Connor E, Fowler SE, Hamman RF, Lachin JM, Walker EA, Nathan DM, Diabetes Prevention Program Research Group (2002) Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med 346(6):393–403. doi:10.1056/NEJMoa012512
4. Lindstrom J, Ilanne-Parikka P, Peltonen M, Aunola S, Eriksson JG, Hemio K, Hamalainen H, Harkonen P, Keinanen-Kiukaanniemi S, Laakso M, Louheranta A, Mannelin M, Paturi M, Sundvall J, Valle TT, Uusitupa M, Tuomilehto J (2006) Sustained reduction in the incidence of type 2 diabetes by lifestyle intervention: follow-up of the Finnish Diabetes Prevention Study. Lancet 368(9548):1673–1679. doi:10.1016/S0140-6736(06)69701-8
5. Kosaka K, Noda M, Kuzuya T (2005) Prevention of type 2 diabetes by lifestyle intervention: a Japanese trial in IGT males. Diabetes Res Clin Pract 67(2):152–162. doi:10.1016/j.diabres.2004.06.010
6. Ramachandran A, Snehalatha C, Mary S, Mukesh B, Bhaskar AD, Vijay V (2006) The Indian Diabetes Prevention Programme shows that lifestyle modification and metformin prevent type 2 diabetes in Asian Indian subjects with impaired glucose tolerance (IDPP-1). Diabetologia 49(2):289–297. doi:10.1007/s00125-005-0097-z
7. Bushman B (2014) Promoting exercise as medicine for prediabetes and prehypertension. Curr Sports Med Rep 13(4):233–239. doi:10.1249/jsr.0000000000000066
8. Lambert EV, Bull F (2014) Public health recommendations for physical activity in the prevention of type 2 diabetes mellitus. Med Sport Sci 60:130–140. doi:10.1159/000357343
9. Fernandes RA, Coelho ESMJ, Spiguel Lima MC, Cayres SU, Codogno JS, Lira FS (2015) Possible underestimation by sports medicine of the effects of early physical exercise practice on the prevention of diseases in adulthood. Curr Diabetes Rev 11(3):201–205
10. Hopper I, Billah B, Skiba M, Krum H (2011) Prevention of diabetes and reduction in major cardiovascular events in studies of subjects with prediabetes: meta-analysis of randomised controlled clinical trials. Eur J Cardiovasc Prev Rehabil 18(6):813–823. doi:10.1177/1741826711421687
11. Schellenberg ES, Dryden DM, Vandermeer B, Ha C, Korownyk C (2013) Lifestyle interventions for patients with and at risk for type 2 diabetes: a systematic review and meta-analysis. Ann Intern Med 159(8):543–551. doi:10.7326/0003-4819-159-8-201310150-00007
12. Hamilton MT, Hamilton DG, Zderic TW (2014) Sedentary behavior as a mediator of type 2 diabetes. Med Sport Sci 60:11–26. doi:10.1159/000357332
13. Saaristo T, Moilanen L, Korpi-Hyovalti E, Vanhala M, Saltevo J, Niskanen L, Jokelainen J, Peltonen M, Oksa H, Tuomilehto J, Uusitupa M, Keinanen-Kiukaanniemi S (2010) Lifestyle intervention for prevention of type 2 diabetes in primary health care one-year follow-up of the Finnish National Diabetes Prevention Program (FIN-D2D). Diabetes Care 33(10):2146–2151. doi:10.2337/Dc10-0410
14. Tuomilehto J, Schwarz P, Lindstrom J (2011) Long-term benefits from lifestyle interventions for type 2 diabetes prevention time to expand the efforts. Diabetes Care 34:S210–S214. doi:10.2337/Dc11-S222
15. Assoc AD (2013) Economic costs of diabetes in the US in 2012. Diabetes Care 36(4):1033–1046. doi:10.2337/Dc12-2625
16. Hermansen K, Baekdal TA, During M, Pietraszek A, Mortensen LS, Jorgensen H, Flint A (2013) Liraglutide suppresses postprandial triglyceride and apolipoprotein B48 elevations after a fat-rich meal in patients with type 2 diabetes: a randomized, double-blind, placebo-controlled, cross-over trial. Diabetes Obes Metab 15(11):1040–1048. doi:10.1111/dom.12133
17. McKeigue PM, Marmot MG, Syndercombe Court YD, Cottier DE, Rahman S, Riemersma RA (1988) Diabetes, hyperinsulinaemia, and coronary risk factors in Bangladeshis in east London. Br Heart J 60(5):390–396
18. Shai I, Jiang R, Manson JE, Stampfer MJ, Willett WC, Colditz GA, Hu FB (2006) Ethnicity, obesity, and risk of type 2 diabetes in women—a 20-year follow-up study. Diabetes Care 29(7):1585–1590. doi:10.2337/Dc06-0057
19. Khoo CM, Sairazi S, Taslim S, Gardner D, Wu Y, Lee J, van Dam RM, Tai ES (2011) Ethnicity modifies the relationships of insulin resistance, inflammation, and adiponectin with obesity in a multiethnic Asian population. Diabetes Care 34(5):1120–1126. doi:10.2337/Dc10-2097
20. Wang C, Li J, Xue H, Li Y, Huang J, Mai J, Chen J, Cao J, Wu X, Guo D, Yu L, Gu D (2014) Type 2 diabetes mellitus incidence in Chinese: contributions of overweight and obesity. Diabetes Res Clin Pract. doi:10.1016/j.diabres.2014.09.059
21. Ryden L, Grant PJ, Anker SD, Berne C, Cosentino F, Danchin N, Deaton C, Escaned J, Hammes HP, Huikuri H, Marre M, Marx N, Mellbin L, Ostergren J, Patrono C, Seferovic P, Uva MS, Taskinen MR, Tendera M, Tuomilehto J, Valensi P, Zamorano JL (2013) ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD. Eur Heart J 34(39):3035–3087. doi:10.1093/eurheartj/eht108
22. Rechel B, Mladovsky P, Ingleby D, Mackenbach JP, McKee M (2013) Migration and health in an increasingly diverse Europe. Lancet 381(9873):1235–1245. doi:10.1016/S0140-6736(12)62086-8
23. Barba C, Cavalli-Sforza T, Cutter J, Darnton-Hill I, Deurenberg P, Deurenberg-Yap M, Gill T, James P, Ko G, Miu AH, Kosulwat V, Kumanyika S, Kurpad A, Mascie-Taylor N, Moon HK, Nishida C, Noor MI, Reddy KS, Rush E, Schultz JT, Seidell J, Stevens J, Swinburn B, Tan K, Weisell R, Wu ZS, Yajnik CS, Yoshiike N, Zimmet P, Consultation WE (2004) Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies. Lancet 363(9403):157–163
24. Chiu M, Austin PC, Manuel DG, Shah BR, Tu JV (2011) Deriving ethnic-specific BMI cutoff points for assessing diabetes risk. Diabetes Care 34(8):1741–1748. doi:10.2337/dc10-2300
25. Carulli L, Rondinella S, Lombardini S, Canedi I, Loria P, Carulli N (2005) Review article: diabetes, genetics and ethnicity. Aliment Pharmacol Ther 22:16–19. doi:10.1111/j.1365-2036.2005.02588.x
26. Yajnik CS, Lubree HG, Rege SS, Naik SS, Deshpande JA, Deshpande SS, Joglekar CV, Yudkin JS (2002) Adiposity and hyperinsulinemia in Indians are present at birth. J Clin Endocr Metab 87(12):5575–5580. doi:10.1210/jc.2002-020434
27. Mckeigue PM, Pierpoint T, Ferrie JE, Marmot MG (1992) Relationship of glucose-intolerance and hyperinsulinemia to body-fat pattern in South Asians and Europeans. Diabetologia 35(8):785–791
28. Who (2004) Appropriate body-mass index in Asian populations and its implications for policy and intervention strategies. Lancet 363(9412):902
29. Misra A, Chowbey P, Makkar BM, Vikram NK, Wasir JS, Chadha D, Joshi SR, Sadikot S, Gupta R, Gulati S, Munjal YP, Concensus G (2009) Consensus statement for diagnosis of obesity, abdominal obesity and the metabolic syndrome for Asian Indians and recommendations for physical activity, medical and surgical management. J Assoc Phys India 57:163–170
30. Bei-Fan Z, Working CMAG (2002) Predictive values of body mass index and waist circumference for risk factors of certain related diseases in Chinese adults: study on optimal cut-off points of body mass index and waist circumference in Chinese adults. Asia Pac J Clin Nutr 11:S685–S693. doi:10.1046/j.1440-6047.11.s8.9.x
31. Hsu WC, Araneta MRG, Kanaya AM, Chiang JL, Fujimoto W (2015) BMI cut points to identify at-risk Asian Americans for type 2 diabetes screening. Diabetes Care 38(1):150–158. doi:10.2337/Dc14-2391
32. Edelstein SL, Knowler WC, Bain RP, Andres R, BarrettConnor EL, Dowse GK, Haffner SM, Pettitt DJ, Sorkin JD, Muller DC, Collins VR, Hamman RF (1997) Predictors of progression from impaired glucose tolerance to NIDDM—an analysis of six prospective studies. Diabetes 46(4):701–710. doi:10.2337/diabetes.46.4.701
33. Shaw JA, Zimmet PZ, de Courten M, Dowse GK, Chitson P, Gareeboo H, Hemraj F, Fareed D, Tuomilehto J, Alberti KGMM (1999) Impaired fasting glucose or impaired glucose tolerance—what best predicts future diabetes in Mauritius? Diabetes Care 22(3):399–402. doi:10.2337/diacare.22.3.399
34. Shaw JE, de Courten M, Boyko EJ, Zimmet PZ (1999) Impact of new diagnostic criteria for diabetes on different populations. Diabetes Care 22(5):762–766. doi:10.2337/diacare.22.5.762
35. Gabir MM, Hanson RL, Dabelea D, Imperatore G, Roumain J, Bennett PH, Knowler WC (2000) The 1997 American Diabetes Association and 1999 World Health Organization criteria for hyperglycemia in the diagnosis and prediction of diabetes. Diabetes Care 23(8):1108–1112. doi:10.2337/diacare.23.8.1108
36. de Vegt F, Dekker JM, Jager A, Hienkens E, Kostense PJ, Stehouwer CDA, Nijpels G, Bouter LM, Heine RJ (2001) Relation of impaired fasting and postload glucose with incident type 2 diabetes in a Dutch population—the Hoorn study. JAMA 285(16):2109–2113. doi:10.1001/jama.285.16.2109
37. Gerstein HC, Santaguida P, Raina P, Morrison KM, Balion C, Hunt D, Yazdi H, Booker L (2007) Annual incidence and relative risk of diabetes in people with various categories of dysglycemia: a systematic overview and meta-analysis of prospective studies. Diabetes Res Clin Pract 78(3):305–312. doi:10.1016/j.diabres.2007.05.004
38. Harris MI, Flegal KM, Cowie CC, Eberhardt MS, Goldstein DE, Little RR, Wiedmeyer HM, Byrd-Holt DD (1998) Prevalence of diabetes, impaired fasting glucose, and impaired glucose tolerance in US adults—the Third National Health and Nutrition Examination Survey, 1988–1994. Diabetes Care 21(4):518–524. doi:10.2337/diacare.21.4.518
39. Stern MP, Williams K, Haffner SA (2002) Identification of persons at high risk for type 2 diabetes mellitus: do we need the oral glucose tolerance test? Ann Intern Med 136(8):575–581
40. Modesti PA, Bianchi S, Borghi C, Cameli M, Capasso G, Ceriello A, Ciccone MM, Germano G, Maiello M, Muiesan ML, Novo S, Padeletti L, Palmiero P, Pillon S, Rotella CM, Saba PS, Scicchitano P, Trimarco B, Volpe M, Pedrinelli R, Di Biase M (2014) Cardiovascular health in migrants: current status and issues for prevention. A collaborative multidisciplinary task force report. J Cardiovasc Med 15(9):683–692. doi:10.2459/Jcm.0000000000000069
41. American Diabetes A (2013) Standards of medical care in diabetes–2013. Diabetes Care 36(Suppl 1):S11–S66. doi:10.2337/dc13-S011
42. Kengne AP, Beulens JWJ, Peelen LM, Moons KGM, van der Schouw YT, Schulze MB, Spijkerman AMW, Griffin SJ, Grobbee DE, Palla L, Tormo MJ, Arriola L, Barengo NC, Barricarte A, Boeing H, Bonet C, Clavel-Chapelon F, Dartois L, Fagherazzi G, Franks PW, Huerta JM, Kaaks R, Key TJ, Khaw KT, Li KR, Muhlenbruch K, Nilsson PM, Overvad K, Overvad TF, Palli D, Panico S, Quiros JR, Rolandsson O, Roswall N, Sacerdote C, Sanchez MJ, Slimani N, Tagliabue G, Tjonneland A, Tumino R, van der A DL, Forouhi NG, Sharp SJ, Langenberg C, Riboli E, Wareham NJ (2014) Non-invasive risk scores for prediction of type 2 diabetes (EPIC-InterAct): a validation of existing models. Lancet Diabetes Endocrinol 2(1):19–29. doi:10.1016/S2213-8587(13)70103-7
43. Lindstrom J, Tuomilehto J (2003) The diabetes risk score—a practical tool to predict type 2 diabetes risk. Diabetes Care 26(3):725–731. doi:10.2337/diacare.26.3.725
44. Buijsse B, Simmons RK, Griffin SJ, Schulze MB (2011) Risk assessment tools for identifying individuals at risk of developing type 2 diabetes. Epidemiol Rev 33(1):46–62. doi:10.1093/epirev/mxq019
45. Collins GS, Mallett S, Omar O, Yu LM (2011) Developing risk prediction models for type 2 diabetes: a systematic review of methodology and reporting. BMC Med. doi:10.1186/1741-7015-9-103
46. Noble D, Mathur R, Dent T, Meads C, Greenhalgh T (2011) Risk models and scores for type 2 diabetes: systematic review. BMJ 343:d7163. doi:10.1136/bmj.d7163
47. Abbasi A, Peelen LM, Corpeleijn E, van der Schouw YT, Stolk RP, Spijkerman AMW, van der A DL, Moons KGM, Navis G, Bakker SJL, Beulens JWJ (2012) Prediction models for risk of developing type 2 diabetes: systematic literature search and independent external validation study. BMJ. doi:10.1136/bmj.e5900
48. Schmidt MI, Duncan BB, Bang H, Pankow JS, Ballantyne CM, Golden SH, Folsom AR, Chambless LE (2005) Identifying individuals at high risk for diabetes—the Atherosclerosis Risk in Communities study. Diabetes Care 28(8):2013–2018. doi:10.2337/diacare.28.8.2013
49. Kahn HS, Cheng YJ, Thompson TJ, Imperatore G, Gregg EW (2009) Two risk-scoring systems for predicting incident diabetes mellitus in US adults age 45–64 years. Ann Intern Med 150(11):741–751
50. Chen L, Magliano DJ, Balkau B, Colagiuri S, Zimmet PZ, Tonkin AM, Mitchell P, Phillips PJ, Shaw JE (2010) AUSDRISK: an Australian type 2 diabetes risk assessment tool based on demographic, lifestyle and simple anthropometric measures. Med J Aust 192(4):197–202
51. Rosella LC, Manuel DG, Burchill C, Stukel TA, team ftP-D (2011) A population-based risk algorithm for the development of diabetes: development and validation of the Diabetes Population Risk Tool (DPoRT). J Epidemiol Commun Health 65(7):613–620. doi:10.1136/jech.2009.102244
52. Hippisley-Cox J, Coupland C, Robson J, Sheikh A, Brindle P (2009) Predicting risk of type 2 diabetes in England and Wales: prospective derivation and validation of QDScore. BMJ. doi:10.1136/bmj.b880
53. Mann DM, Bertoni AG, Shimbo D, Carnethon MR, Chen HY, Jenny NS, Muntner P (2010) Comparative validity of 3 diabetes mellitus risk prediction scoring models in a multiethnic US cohort. Am J Epidemiol 171(9):980–988. doi:10.1093/Aje/Kwq030
54. Merlotti C, Morabito A, Pontiroli AE (2014) Prevention of type 2 diabetes; a systematic review and meta-analysis of different intervention strategies. Diabetes Obes Metab 16(8):719–727. doi:10.1111/dom.12270
55. Saito T, Watanabe M, Nishida J, Izumi T, Omura M, Takagi T, Fukunaga R, Bandai Y, Tajima N, Nakamura Y, Ito M (2011) Lifestyle modification and prevention of type 2 diabetes in overweight Japanese with impaired fasting glucose levels A Randomized Controlled Trial. Arch Intern Med 171(15):1352–1360
56. Sakane N, Sato J, Tsushita K, Tsujii S, Kotani K, Tsuzaki K, Tominaga M, Kawazu S, Sato Y, Usui T, Kamae I, Yoshida T, Kiyohara Y, Sato S, Kuzuya H (2011) Prevention of type 2 diabetes in a primary healthcare setting: three-year results of lifestyle intervention in Japanese subjects with impaired glucose tolerance. BMC Public Health 11(1):40. doi:10.1186/1471-2458-11-40
57. Iqbal Hydrie MZ, Basit A, Shera AS, Hussain A (2012) Effect of intervention in subjects with high risk of diabetes mellitus in pakistan. J Nutr Metab 2012:867604. doi:10.1155/2012/867604
58. Ramachandran A, Snehalatha C, Ram J, Selvam S, Simon M, Nanditha A, Shetty AS, Godsland IF, Chaturvedi N, Majeed A, Oliver N, Toumazou C, Alberti KG, Johnston DG (2013) Effectiveness of mobile phone messaging in prevention of type 2 diabetes by lifestyle modification in men in India: a prospective, parallel-group, randomised controlled trial. Lancet Diabetes Endocrinol 1(3):191–198. doi:10.1016/S2213-8587(13)70067-6
59. Bhopal RS, Douglas A, Wallia S, Forbes JF, Lean ME, Gill JM, McKnight JA, Sattar N, Sheikh A, Wild SH, Tuomilehto J, Sharma A, Bhopal R, Smith JB, Butcher I, Murray GD (2014) Effect of a lifestyle intervention on weight change in south Asian individuals in the UK at high risk of type 2 diabetes: a family-cluster randomised controlled trial. Lancet Diabetes Endocrinol 2(3):218–227. doi:10.1016/s2213-8587(13)70204-3
60. National_Diabetes_Research_Group (1981) A mass survey of diabetes mellitus in a population of 300,000 in 14 provinces and municipalities in China (author’s transl). Zhonghua Nei Ke Za Zhi 20(11):678–683
61. Pan XR, Yang WY, Li GW, Liu J (1997) Prevalence of diabetes and its risk factors in China, 1994. Diabetes Care 20(11):1664–1669. doi:10.2337/diacare.20.11.1664
62. Li GW, Zhang P, Wang JP, Gregg EW, Yang WY, Gong QH, Li H, Li HL, Jiang YY, An YL, Shuai Y, Zhang B, Zhang JL, Thompson TJ, Gerzoff RB, Roglic G, Hu YH, Bennett PH (2008) The long-term effect of lifestyle interventions to prevent diabetes in the China Da Qing Diabetes Prevention Study: a 20-year follow-up study. Lancet 371(9626):1783–1789. doi:10.1016/S0140-6736(08)60766-7
63. Xu Y, Wang L, He J, Bi Y, Li M, Wang T, Wang L, Jiang Y, Dai M, Lu J, Xu M, Li Y, Hu N, Li J, Mi S, Chen CS, Li G, Mu Y, Zhao J, Kong L, Chen J, Lai S, Wang W, Zhao W, Ning G (2013) Prevalence and control of diabetes in Chinese adults. JAMA 310(9):948–959. doi:10.1001/jama.2013.168118
64. Modesti PA (2015) Ethnicity: new challenge for cardiovascular prevention in Europe. Hypertension 66(3):464–465. doi:10.1161/HYPERTENSIONAHA.115.05777
65. Gillies CL, Lambert PC, Abrams KR, Sutton AJ, Cooper NJ, Hsu RT, Davies MJ, Khunti K (2008) Different strategies for screening and prevention of type 2 diabetes in adults: cost effectiveness analysis. BMJ 336(7654):1180. doi:10.1136/bmj.39545.585289.25
66. Admiraal WM, Vlaar EM, Nierkens V, Holleman F, Middelkoop BJ, Stronks K, van Valkengoed IG (2013) Intensive lifestyle intervention in general practice to prevent type 2 diabetes among 18–60-year-old South Asians: 1-year effects on the weight status and metabolic profile of participants in a randomized controlled trial. PLoS One 8(7):e68605. doi:10.1371/journal.pone.0068605
67. Rose G (1981) Strategy of prevention: lessons from cardiovascular disease. Br Med J (Clin Res Ed) 282(6279):1847–1851
68. Latham K, Wu B (2013) Chinese immigration into the EU: new trends, dynamics and implications. 1–65. http://www.chathamhouse.org/sites/files/chathamhouse/public/Research/Asia/0313ecran_lathamwu.pdf
69. Zhou M, Astell-Burt T, Bi Y, Feng X, Jiang Y, Li Y, Page A, Wang L, Xu Y, Wang L, Zhao W, Ning G (2015) Geographical variation in diabetes prevalence and detection in china: multilevel spatial analysis of 98,058 adults. Diabetes Care 38(1):72–81. doi:10.2337/dc14-1100
70. Modesti PA, Han Y, Jing Y, Xiaoling W, Mengyue Z, Zihua Y, Jia G, Perruolo E, Bini L, Camera M, Biggeri A, Rapi S, Hongsheng C, Li Z, Zengli W, Jianbin H, Xiaoyue Z, Zhao D (2014) Design and arrangement of the CHIP (CHinese In Prato) study. Epidemiol Prev 38(6):357–363
71. Stuart-Shor EM, Berra KA, Kamau MW, Kumanyika SK (2012) Behavioral strategies for cardiovascular risk reduction in diverse and underserved racial/ethnic groups. Circulation 125(1):171–184. doi:10.1161/circulationaha.110.968495
72. Grace C, Begum R, Subhani S, Kopelman P, Greenhalgh T (2008) Prevention of type 2 diabetes in British Bangladeshis: qualitative study of community, religious, and professional perspectives. BMJ 337:a1931. doi:10.1136/bmj.a1931
73. Artinian NT, Fletcher GF, Mozaffarian D, Kris-Etherton P, Van Horn L, Lichtenstein AH, Kumanyika S, Kraus WE, Fleg JL, Redeker NS, Meininger JC, Banks J, Stuart-Shor EM, Fletcher BJ, Miller TD, Hughes S, Braun LT, Kopin LA, Berra K, Hayman LL, Ewing LJ, Ades PA, Durstine JL, Houston-Miller N, Burke LE, American Heart Association Prevention Committee of the Council on Cardiovascular N (2010) Interventions to promote physical activity and dietary lifestyle changes for cardiovascular risk factor reduction in adults: a scientific statement from the American Heart Association. Circulation 122(4):406–441. doi:10.1161/CIR.0b013e3181e8edf1